Tangdu Hospital, Air Force Medical University
Welcome,         Profile    Billing    Logout  
 0 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gao, Bin
PB119, NCT04504370: Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects

Completed
3
273
RoW
GLP-1 receptor agonist, Placebo, PB-119 Placebo
PegBio Co., Ltd.
Type 2 Diabetes Mellitus (T2DM)
03/22
11/22
NCT04504396: Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy

Completed
3
620
RoW
GLP-1 receptor agonist, Placebo, PB-119 Placebo
PegBio Co., Ltd.
Type 2 Diabetes Mellitus (T2DM)
09/22
05/23
NCT05102149: Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus

Recruiting
3
672
RoW
PB-201, Vildagliptin, PB-201 matched placebo, Vildagliptin matched placebo
PegBio Co., Ltd.
Type 2 Diabetes Mellitus (T2DM)
11/23
04/25
EPICT, NCT04066764: Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

Recruiting
3
200
RoW
Rivaroxaban, Xarelto, Warfarin, coumadin, Nadroparin, Fraxiparin
Second Affiliated Hospital, School of Medicine, Zhejiang University, Sir Run Run Shaw Hospital, Huadong Hospital, Shanghai Zhongshan Hospital, Shanghai 5th People's Hospital, Yantai Yuhuangding Hospital, Anhui Provincial Hospital
Venous Thromboembolism
10/24
10/24
PLICTS, NCT04067505: Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The Study

Recruiting
3
224
RoW
Rivaroxaban, Xarelto, Warfarin, coumadin, Nadroparin, Fraxiparin
Second Affiliated Hospital, School of Medicine, Zhejiang University, Sir Run Run Shaw Hospital, Huadong Hospital, Shanghai Zhongshan Hospital, Shanghai 5th People's Hospital, Yantai Yuhuangding Hospital, Anhui Provincial Hospital, Zhejiang Provincial People's Hospital, Zhejiang Hospital
May-Thurner Syndrome
12/24
12/24
Yuan, Lijun
NCT05043181: Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH

Not yet recruiting
1
30
RoW
Low Density Lipoprotein Receptor mRNA Exosomes
Tang-Du Hospital, Air Force Military Medical University, China
Familial Hypercholesterolemia
12/26
12/26
NCT04881292: RF Based QIMT & QAS Study on Chinese Adults

Recruiting
N/A
3500
RoW
Tang-Du Hospital, Esaote (Shenzhen) Medical Equipment Co. Ltd, The First Affiliated Hospital, Zhejiang University School of Medicine, Shannxi Provincial People's Hospital, Shengjing Hospital, First Hospital of China Medical University, Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Renmin Hospital of Wuhan University, Beijing University of Chinese Medicine Third Affiliated Hospital, The First Affiliated Hospital of Shanxi Medical University, The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, The First Hospital of Jilin University, The Afffiliated Hospital of Guizhou Medical University, Yan An Hospital Affiliated to Kunming Medical University, Second Affiliated Hospital of Guangzhou Medical University, Third Xiangya Hospital of Central South University, Ruijin Hospital, The First Affiliated Hospital with Nanjing Medical University, The First Affiliated Hospital of Anhui Medical University, The Second Hospital of Anhui Medical University, The First Affiliated Hospital of USTC, The Affiliated Hospital of Qingdao University, First Affiliated Hospital of Xinjiang Medical University, Hospital of Northwestern Polytechnical University, GEM Flower Xian Changqing Staff Hospital, Xi'an Central Hospital, The Second Affiliated Hospital of Xi'an Medical University, Second Affiliated Hospital of Xi'an Jiaotong University, First Affiliated Hospital of Guangxi Medical University, Karamay Central Hospital of Xinjiang, The Fourth Affiliated Hospital of Xinjiang Medical University, Xi'an No.1 Hospital, Xianyang Hospital of Yan'an University, General Hospital of Xinjiang Production and Construction Corps, Air Force Medical Center
Healthy, Adults, Carotid Intima-media Thickness, Vascular Stiffness, Chinese
05/22
05/22
Xing, Changyang
NCT04881292: RF Based QIMT & QAS Study on Chinese Adults

Recruiting
N/A
3500
RoW
Tang-Du Hospital, Esaote (Shenzhen) Medical Equipment Co. Ltd, The First Affiliated Hospital, Zhejiang University School of Medicine, Shannxi Provincial People's Hospital, Shengjing Hospital, First Hospital of China Medical University, Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Renmin Hospital of Wuhan University, Beijing University of Chinese Medicine Third Affiliated Hospital, The First Affiliated Hospital of Shanxi Medical University, The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, The First Hospital of Jilin University, The Afffiliated Hospital of Guizhou Medical University, Yan An Hospital Affiliated to Kunming Medical University, Second Affiliated Hospital of Guangzhou Medical University, Third Xiangya Hospital of Central South University, Ruijin Hospital, The First Affiliated Hospital with Nanjing Medical University, The First Affiliated Hospital of Anhui Medical University, The Second Hospital of Anhui Medical University, The First Affiliated Hospital of USTC, The Affiliated Hospital of Qingdao University, First Affiliated Hospital of Xinjiang Medical University, Hospital of Northwestern Polytechnical University, GEM Flower Xian Changqing Staff Hospital, Xi'an Central Hospital, The Second Affiliated Hospital of Xi'an Medical University, Second Affiliated Hospital of Xi'an Jiaotong University, First Affiliated Hospital of Guangxi Medical University, Karamay Central Hospital of Xinjiang, The Fourth Affiliated Hospital of Xinjiang Medical University, Xi'an No.1 Hospital, Xianyang Hospital of Yan'an University, General Hospital of Xinjiang Production and Construction Corps, Air Force Medical Center
Healthy, Adults, Carotid Intima-media Thickness, Vascular Stiffness, Chinese
05/22
05/22

Download Options